We use Advanced Medical Testing insights to make IV therapies that fit your health needs
Tirzepatide and semaglutide, both GLP-1 receptor agonists, have shown significant efficacy in weight loss and metabolic improvements, while dapagliflozin, an SGLT2 inhibitor, offers renal protection alongside metabolic benefits
It is studied in redox-state measurement, oxidative stress assays and analytical method development
Research has relayed the potential to elevate GLP-1 levels and support blood sugar regulation via bioactive ginsenosides
Not only do I love supporting people on their weight loss journeys, but Ive been on one myself and have experienced these medications firsthand
In lactating rats, tirzepatide was detected in milk, though the clinical significance of these findings for humans is uncertain due to physiological differences between species